Researchers Re-Examine old data to find who benefits from extra antibiotic for staph blood infection
NCT ID NCT07155590
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study looks at data from 369 adults who had a serious staph infection in their blood. Researchers want to see if adding the antibiotic fosfomycin to standard treatment helps certain patients more than others. They will group patients by their infection type and risk level to find who might benefit most. This is a re-analysis of past trial data, not a new treatment test.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCAL AUREUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Catalonia, 08907, Spain
-
Hospital Universitario Virgen de Macarena
Seville, 41009, Spain
Conditions
Explore the condition pages connected to this study.